Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Recruiting now · Not applicable

Conditions studied: Smoking Behaviors

In brief

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Key facts

Study ID

NCT07102082

Run by

Roswell Park Cancer Institute

People needed

160

Starts

2025-09-25

Expected to finish

2027-09-30

Last updated by the study team

2026-06-01

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
• Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
• Open to trying a non-combusted oral tobacco product.
• Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
• Have the ability to read, write, and communicate in English.
• Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure

You may not qualify if…

• Plan to quit smoking in the next 30 days.
• Use of smokeless tobacco at least weekly in the last 6 months.
• Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
• Unwilling or unable to follow protocol requirements.
• Pregnant or planning to become pregnant (by self report)

Where it is running

• Roswell Park — Buffalo, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.